Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist illustration of a pill with a molecular structure background.

Jul 27, 2026

Insights from SLAS Europe 2026 - SelectScience interview

In a recent discussion at SLAS Europe 2026, insights were shared regarding the innovative work at the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), particularly in the realm of proximity-inducing drugs.The ITMP focuses on bridging academic research with industrial applications, emphasizing the integration of drug screening and medical data science. This approach aims to enhance drug discovery by combining traditional laboratory work with data-driven methodologies, ulti
A handshake over a contract in an office setting

Jul 27, 2026

Home Control's Orbiva Signs Strategic MOU with Indonesia's Articura to Advance Localized Healthcare AI and AIoT Digital Health Ecosystem

Home Control's subsidiary, Orbiva, has formed a strategic partnership with Indonesia's Articura to enhance the country's healthcare AI landscape.The collaboration, formalized through a memorandum of understanding (MOU) on July 23, 2026, aims to integrate Orbiva's expertise in AI and AIoT technologies with Articura's local healthcare knowledge. This partnership seeks to develop tailored digital health solutions that comply with Indonesia's regulatory and data sovereignty requirements. Key areas o
A minimalist representation of a DNA double helix symbolizing biotechnology investment.

Jul 27, 2026

Chinese biotech overtakes AI as emerging-market growth trade

As the enthusiasm for AI investments wanes in emerging markets, Chinese biotechnology is emerging as a compelling alternative for growth-oriented investors.Recent trends indicate a significant downturn in the performance of major tech stocks associated with the AI boom, exemplified by declines in companies like SK Hynix and Samsung Electronics. In contrast, several Chinese pharmaceutical firms have seen substantial gains, positioning healthcare as the standout sector in emerging markets, as repo
A patient's hand interacting with a digital health coach in a consultation room

Jul 27, 2026

Tāmaki Health launches New Zealand’s first primary care AI health coach

Tāmaki Health has made a groundbreaking move by introducing New Zealand's first AI health coach into primary care, collaborating with digital health firm Groov. This initiative signifies a pivotal advancement in the integration of artificial intelligence within frontline healthcare services. The AI health coach is designed to enhance Tāmaki Health's existing health coaching program, offering patients tailored support throughout their healthcare journey—before, during, and after medical appointme
Silhouette of a pound sterling coin on a solid background

Jul 27, 2026

UK Startups Pull In $17 Billion In H1 2026, With AI Taking The Lion’s Share

UK startups have experienced a significant fundraising boost, securing $17 billion in the first half of 2026, marking their most successful six-month period since 2022. This surge solidifies the UK’s position as the leading venture capital market in Europe.Artificial intelligence has emerged as the dominant sector, attracting an impressive 74% of all venture capital investments in the UK during this timeframe. This trend underscores the growing investor focus on AI infrastructure, large language
A patient intake form on a desk in a clinical setting

Jul 27, 2026

Reciprocal Clinical Trials

Massive Bio and Sequence Me Now have joined forces to enhance patient access to oncology clinical trials through a new partnership.This collaboration utilizes Massive Bio's AI-driven trial-matching platform to assist patients who have received genomic sequencing results in finding relevant clinical studies based on their specific cancer types and biomarkers. Sequence Me Now will feature Massive Bio on its "Find a Trial" page, while Massive Bio will create a dedicated landing page for Sequence Me
Minimalist representation of growth and partnership in biopharmaceuticals

Jul 27, 2026

Harbour BioMed Forecasts Record H1 2026 Profit as Strategic Partnerships Drive Growth

Harbour BioMed is anticipating significant growth in the first half of 2026, driven by strategic partnerships and advancements in AI-driven drug discovery.The biopharmaceutical company expects revenues to reach between $120 million and $125 million, marking a 19% to 24% increase compared to the same period in 2025. This anticipated growth is coupled with projected profits ranging from $62 million to $67 million, reinforcing Harbour BioMed's position in the market after achieving seven consecutiv
A flat illustration of a drug compound in a minimalist style.

Jul 27, 2026

Chinese biotech is stealing the emerging market trade that AI dominated for two years

Recent trends indicate a significant shift in investment focus from AI-driven stocks to Chinese biotech firms, reflecting changing perceptions of market valuations.In the first quarter of 2025, Chinese companies surged to represent 32% of global biotech licensing deal value, a notable increase from 21% in the previous two years. This shift is largely attributed to Western pharmaceutical companies seeking new pipelines amid patent expirations. Major players like Jiangsu Hengrui and BeiGene have d
A speech bubble and hand symbolizing patient voices in healthcare.

Jul 26, 2026

New AI platform aims to give patients a strong voice in medicines funding

Boehringer Ingelheim has introduced an innovative AI platform called 'Patient Input Buddy' to enhance patient engagement in the evaluation of medicines funding.This new tool aims to simplify the process for patients to contribute their perspectives to the Pharmaceutical Benefits Advisory Committee (PBAC). By collaborating with various patient organizations, Boehringer Ingelheim seeks to ensure that patient voices are more effectively integrated into decision-making processes regarding pharmaceut
AI chip on a workbench in a semiconductor facility

Jul 26, 2026

AI Chip Stocks Fuel Europe's Most Concentrated Market Rally in Years

Europe's stock market is witnessing a significant rally largely fueled by a select group of AI chip companies, marking one of the most concentrated market advances in recent years.Recent analyses indicate that a small number of artificial intelligence semiconductor firms are driving the upward momentum in Europe’s stock markets. This trend highlights the growing impact of AI on global financial markets, as investors are increasingly channeling funds into companies involved in AI hardware, advanc
A pharmaceutical vial on a stainless steel surface in a manufacturing facility.

Jul 26, 2026

TELEO Acquires SmartFactory Rx: Pharma Automation Impact

TELEO Capital Management has acquired SmartFactory Rx, now rebranded as Modersys, focusing on operational intelligence software for the life sciences sector.This acquisition marks a significant transition from a large industrial technology firm, Applied Materials, to a private equity-backed company with a specialized focus on pharmaceuticals and nutritional manufacturing. The change in ownership is poised to allow for more targeted investments in product development, but customers should approac
A minimalist illustration of a coin symbolizing funding.

Jul 25, 2026

CARPL.ai Raises USD 10 Million in Series A Funding Led by IFC

CARPL.ai, an innovative player in the radiology AI sector, has successfully secured USD 10 million in Series A funding, primarily led by the International Finance Corporation (IFC).This funding round also saw participation from existing investor Stellaris Venture Partners and other contributors. The newly acquired capital will be instrumental in enhancing CARPL.ai's product offerings, fostering a robust global partner network, and driving commercial expansion in key regions such as North America